SLC38A5 and breast cancer: Dual targeting of SLC6A14 with SLC25A15, SLC12A4, SLC1A5 and SLC38A5 also reduced growth in MCF7 and MDA-MB-231 human breast cancer cell lines (Extended Data Fig. 5b,c).